MAPT and Alzheimer disease: For example, ganglioside treatment mitigated toxicity triggered by fibrillar Aβ in organotypic hippocampal slice cultures [29], reduced Aβ plaque deposition, tau phosphorylation, and cognitive dysfunction in AD model mice [14, 45], and appeared to slow further deterioration in a small number of AD patients with early-onset disease [48].